This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ahmad, N. Articles by Mukhtar, H. Search for Related Content PubMed PubMed Citation Articles by Ahmad, N. Articles by Mukhtar, H.

Differential Antiproliferative and Apoptotic Response of Sanguinarine for Cancer Cells versus Normal Cells¹

Department of Dermatology [N. A., S. G., M. M. H., H. M.] and Department of Anatomy, School of Medicine [K. M. H.], Case Western Reserve University, Cleveland, Ohio 44106

Sanguinarine, derived from the root of Sanguinaria canadendid, has been shown to possess antimicrobial, anti-inflammatory, and antioxidant properties. Here we compared the antiproliferative and apoptotic potential of sanguinarine against human epidermoid carcinoma (A431) cells and normal human epidermal keratinocytes (NHEKs). Sanguinarine treatment was found to result in a dose-dependent decrease in the viability of A431 cells as well as NHEKs albeit at different levels because sanguinarine-mediated loss of viability occurred at lower doses and was much more pronounced in the A431 carcinoma cells than in the normal keratinocytes. DNA ladder assay demonstrated that compared to vehicle-treated control, sanguinarine treatment of A431 cells resulted in an induction of apoptosis at 1-, 2-, and 5-µM doses. Sanguinarine treatment did not result in the formation of a DNA ladder in NHEKs, even at the very high dose of 10 µM. The induction of apoptosis by sanguinarine was also evident by confocal microscopy after labeling the cells with annexin V. This method also identified necrotic cells, and sanguinarine treatment also resulted in the necrosis of A431 cells. The NHEKs showed exclusively necrotic staining at high doses (2 and 5 µM). We also explored the possibility of cell cycle perturbation by sanguinarine in A431 cells. The DNA cell cycle analysis revealed that sanguinarine treatment did not significantly affect the distribution of cells among the different phases of the cell cycle in A431 cells. We suggest that sanguinarine could be developed as an anticancer drug.

This article has been cited by other articles:

				V. Venkateswaran, L. H. Klotz, M. Ramani, L. M. Sugar, L. E. Jacob, R. K. Nam, and N. E. Fleshner A Combination of Micronutrients Is Beneficial in Reducing the Incidence of Prostate Cancer and Increasing Survival in the Lady Transgenic Model Cancer Prevention Research, May 1, 2009; 2(5): 473 - 483. [Abstract] [Full Text] [PDF]

				A. R. Hussain, N. A. Al-Jomah, A. K. Siraj, P. Manogaran, K. Al-Hussein, J. Abubaker, L. C. Platanias, K. S. Al-Kuraya, and S. Uddin Sanguinarine-Dependent Induction of Apoptosis in Primary Effusion Lymphoma Cells Cancer Res., April 15, 2007; 67(8): 3888 - 3897. [Abstract] [Full Text] [PDF]

				S. Hallock, S.-C. Tang, L. M. Buja, B. F. Trump, A. Liepins, and P. Weerasinghe Aurintricarboxylic Acid Inhibits Protein Synthesis Independent, Sanguinarine-Induced Apoptosis and Oncosis Toxicol Pathol, February 1, 2007; 35(2): 300 - 309. [Abstract] [Full Text] [PDF]

				K. W. Yip, X. Mao, P.Y. B. Au, D. W. Hedley, S. Chow, S. Dalili, J. D. Mocanu, C. Bastianutto, A. Schimmer, and F.-F. Liu Benzethonium Chloride: A Novel Anticancer Agent Identified by Using a Cell-Based Small-Molecule Screen. Clin. Cancer Res., September 15, 2006; 12(18): 5557 - 5569. [Abstract] [Full Text] [PDF]

				J. Huh, A. Liepins, J. Zielonka, C. Andrekopoulos, B. Kalyanaraman, and A. Sorokin Cyclooxygenase 2 Rescues LNCaP Prostate Cancer Cells from Sanguinarine-Induced Apoptosis by a Mechanism Involving Inhibition of Nitric Oxide Synthase Activity. Cancer Res., April 1, 2006; 66(7): 3726 - 3736. [Abstract] [Full Text] [PDF]

				S. Reagan-Shaw, J. Breur, and N. Ahmad Enhancement of UVB radiation-mediated apoptosis by sanguinarine in HaCaT human immortalized keratinocytes. Mol. Cancer Ther., February 1, 2006; 5(2): 418 - 429. [Abstract] [Full Text] [PDF]

				V. M. Adhami, M. H. Aziz, S. R. Reagan-Shaw, M. Nihal, H. Mukhtar, and N. Ahmad Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery Mol. Cancer Ther., August 1, 2004; 3(8): 933 - 940. [Abstract] [Full Text] [PDF]

				V. M. Adhami, M. H. Aziz, H. Mukhtar, and N. Ahmad Activation of Prodeath Bcl-2 Family Proteins and Mitochondrial Apoptosis Pathway by Sanguinarine in Immortalized Human HaCaT Keratinocytes Clin. Cancer Res., August 1, 2003; 9(8): 3176 - 3182. [Abstract] [Full Text] [PDF]

				S. Gupta, K. Hastak, N. Ahmad, J. S. Lewin, and H. Mukhtar Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols PNAS, August 10, 2001; (2001) 171326098. [Abstract] [Full Text] [PDF]

				S. Gupta, K. Hastak, N. Ahmad, J. S. Lewin, and H. Mukhtar Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols PNAS, August 28, 2001; 98(18): 10350 - 10355. [Abstract] [Full Text] [PDF]